US judge says China's Huawei Technologies must face criminal case for racketeering and other charges
U.S. District Judge Ann Donnelly on Tuesday rejected Huawei's request to dismiss the allegations in a 16-count federal indictment against the company, saying in a 52-page ruling that its arguments were premature.
The company did not immediately respond to a request for comment.
The U.S. accuses Huawei and some of its subsidiaries of plotting to steal U.S. trade secrets, installing surveillance equipment that enabled Iran to spy on protesters during 2009 anti-government demonstrations in Iran, and of doing business in North Korea despite U.S. sanctions there.
During President Donald Trump's first term in office, his administration raised national security concerns and began lobbying Western allies against including Huawei in their wireless, high-speed networks.
In its January 2019 indictment, the Justice Department accused Huawei of using a Hong Kong shell company called Skycom to sell equipment to Iran in violation of U.S. sanctions and charged its chief financial officer, Meng Wanzhou, with fraud by misleading the HSBC bank about the company's business dealings in Iran.
Meng, the daughter of Huawei's founder, was arrested in Canada in late 2018 on a U.S. extradition request but released in September 2021 in a high-stakes prisoner swap that freed two Canadians held by China and allowed her to return home.
Chinese officials have accused the U.S. government of 'economic bullying' and of improperly using national security as a pretext for 'oppressing Chinese companies.' In their motion to dismiss the broad criminal case, among other arguments Huawei's lawyers contended that the U.S. allegations were too vague and some were 'impermissibly extraterritorial," and do not involve domestic wire and bank fraud.
The biggest maker of network gear, Huawei struggled to hold onto its market share under sanctions that have blocked its access to most U.S. processor chips and other technology. The limits led it to ramp up its own development of computer chips and other advanced technologies.
The company also shifted its focus to the Chinese market and to network technology for hospitals, factories and other industrial customers and other products that would not be affected by U.S. sanctions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now?
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Omega Healthcare Investors Inc. (NYSE:OHI) is a real estate investment trust that primarily invests in skilled nursing and assisted living facilities in the U.S. and the U.K. It is set to report its Q2 2025 earnings on July 31. Wall Street analysts expect the company to post EPS of $0.75, up from $0.71 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $295.80 million, up from $252.75 million a year earlier. Don't Miss: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. . Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — The company's stock traded at approximately $34.79 per share 10 years ago. If you had invested $10,000, you could have bought roughly 287 shares. Currently, shares trade at $36.67, meaning your investment's value could have grown to $10,540 from stock price appreciation alone. However, Omega Healthcare also paid dividends during these 10 years. Omega Healthcare's dividend yield is currently 7.31%. Over the last 10 years, it has paid about $27.11 in dividends per share, which means you could have made $7,792 from dividends alone. Summing up $10,540 and $7,792, we end up with the final value of your investment, which is $18,332. This is how much you could have made if you had invested $10,000 in Omega Healthcare stock 10 years ago. This means a total return of 83.32%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 256.40%. Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — Omega Healthcare has a consensus rating of "Buy" and a price target of $36.28 based on the ratings of 20 analysts. The price target implies around 1% potential downside from the current stock price. The company on May 1 announced its Q1 2025 earnings, posting FFO of $0.75, beating the consensus estimate of $0.74, while revenues of $276.80 million came in below the consensus of $288.69 million, as reported by Benzinga. "We are pleased with our first quarter results, as we continue to grow FAD per share, while further de-levering the balance sheet. We have accretively invested approximately $423 million year-to-date through April 30th and, as a result, we are increasing our 2025 AFFO guidance to be between $2.95 and $3.01 per share from our previous guidance of between $2.90 and $2.98 per share," said CEO Taylor Pickett. Check out this article by Benzinga for four analysts' insights on Omega Healthcare. Given no expected upside potential, growth-focused investors may not find Omega Healthcare stock attractive. Conversely, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 7.31%. Read Next: Maximize saving for your retirement and cut down on taxes: . , which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum. Image: Shutterstock This article If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now? originally appeared on
Yahoo
20 minutes ago
- Yahoo
21-year-old man in critical condition after shooting near Bronx pool
A 21-year-old man was shot and critically wounded outside of a neighborhood pool in the Bronx, police said Sunday. Shots rang out around 3:40 p.m. near Fulton Ave. and E. 173rd St. in Morrisania, striking the victim in the neck, cops said. EMS transported him to St. Barnabas Hospital, where he remains in critical condition. The shooting took place just before the nearby Crotona Park Pool opened for its afternoon session. There was no immediate arrest as police continue to investigate. At the end of May, 21-year-old Irvin Provitt died after taking a gunshot to the head in Crotona Park. A neighborhood resident who spoke to the Daily News after Provitt's death said the playground where the shooting happened is a trouble spot. 'It's always hot,' said Jennifer Ramos, 34. 'There's always a lot of gang activity. Especially in the summer time.'
Yahoo
26 minutes ago
- Yahoo
The Company Behind Walmart's Great Value Ice Cream Is Bigger Than You Might Expect
Walmart shoppers know that the corporate giant has its own house brand called Great Value. And shoppers on a budget know that this brand, found amongst the scores of other name brands that Walmart carries, is often priced lower than the others. In my personal experience, the Great Value brand is just as good as fancier brands. Come to find out, this is because some of these fancier brands actually make Great Value brand products. For example, Sara Lee makes Great Value breads, and Kellogg's (whose major cereal recall took millions of boxes off shelves) produces some Great Value cereals. When it comes to Walmart's ice creams, a company called Wells Dairy has been churning out the Great Value brand for decades. You may not recognize the name, but you'll know many of the ice creams it makes. Located in Le Mars, Iowa, which is also known as the Ice Cream Capital of the World, Wells Dairy (which is now officially called Wells Enterprises) began in 1913 as a horse-drawn wagon milk delivery service. In 1925, it began making ice cream and hasn't stopped. Not only does Wells Dairy make Great Value ice cream, but it also produces the frozen treats for Blue Bunny, Halo Top, Bomb Pop, and Blue Ribbon Classics. The dairy manufacturer is so huge that overall production requires a 900,000 square foot plant and a freezer that is 12 stories tall. And this is just in Le Mars; the company also has a production facility in New York. Overall, Wells Dairy makes over 150 million gallons of ice cream every year. Read more: Brands Of Vanilla Ice Cream Ranked From Worst To Best Churning out Great Value brand ice cream is undoubtedly a huge piece of Wells Enterprises' business, but the size and overall impact that the company has made in the frozen treat world is also notable. There is an entire Wells Enterprises visitors center in Le Mars where throngs of tourists visit every year to sample ice cream (the ice cream parlor has 40 flavors to choose from), tour the facilities, and get a glimpse of how all that ice cream is made every day. If you like the Great Value brand Sea Salt Caramel ice cream flavor, which we found to taste just as good as other brand names, try the parlor's Salted Caramel Craze flavor and see how it compares. Wells didn't always make Great Value ice cream. In fact, the relationship between the two corporations began with a Walmart store in Kansas selling the Blue Bunny line of ice cream, which Wells was already making at the time. In what would become an enormous business relationship, Wells agreed to make the Great Value brand of ice cream, while Walmart would continue to sell Blue Bunny (not to mention Halo Top, Bomb Pops, and Blue Ribbon) in its stores, even when offered right next to its own house brand. If you like Bomb Pops, we ranked some flavors to find the one that reigns supreme. For more food and drink goodness, join The Takeout's newsletter. Get taste tests, food & drink news, deals from your favorite chains, recipes, cooking tips, and more! Read the original article on The Takeout.
